InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: ss0722 post# 42621

Tuesday, 12/19/2017 10:00:21 PM

Tuesday, December 19, 2017 10:00:21 PM

Post# of 48316
More important is that Oncosec release positive interim PISCES data next year which leads to a fast track FDA approval and commercialization in 2019. The cutback on orphan drug write-offs sucks but at least orphan drugs still carry 7 years of exclusivity. I don't think Merck will mind that much when they buyout Oncosec.